Difference between revisions of "Behaviour Modifying Drugs - Overview"

From WikiVet English
Jump to navigation Jump to search
Line 7: Line 7:
 
*'''[[Fluoxetine]]''' (EU and USA license for the treatment of separation anxiety in dogs, when used in combination with behavioural therapy. Subsequently withdrawn from European market).
 
*'''[[Fluoxetine]]''' (EU and USA license for the treatment of separation anxiety in dogs, when used in combination with behavioural therapy. Subsequently withdrawn from European market).
  
 +
No psychoactive drugs are licensed for use in cats.
 
A range of other drugs are used to treat behavioural conditions, including beta-adrenoceptor antagonists, benzodiazepines, azapirones, anticonvulsants and triazolopyridines.
 
A range of other drugs are used to treat behavioural conditions, including beta-adrenoceptor antagonists, benzodiazepines, azapirones, anticonvulsants and triazolopyridines.
 
Some of these drugs are licensed for use in a companion animal species for another condition, but many are not licensed for use in any companion animal species.  
 
Some of these drugs are licensed for use in a companion animal species for another condition, but many are not licensed for use in any companion animal species.  
Line 18: Line 19:
 
| '''Tranquillisers''' || Acepromazine || Sedation/restraint (no specific indication in behavioural therapy) || Hypotension, CNS stimulation, contradictory responses. Caution in boxers and greyhounds
 
| '''Tranquillisers''' || Acepromazine || Sedation/restraint (no specific indication in behavioural therapy) || Hypotension, CNS stimulation, contradictory responses. Caution in boxers and greyhounds
 
|-
 
|-
| '''Benzodiazepines '''|| Alprazolam, Clonazepam, Clorazepate, Diazepam, Lorazepam, Oxazepam || [[Feline Fear and Stress|Acute anxiety, panic, short-term management of noise phobias]]  || Hepatic necrosis after oral dosing (potentially fatal), Sedation, ataxia, increased appetite, paradoxical excitation
+
| '''Benzodiazepines '''|| Alprazolam, Clonazepam, Clorazepate, Diazepam, Lorazepam, Oxazepam || [[Feline Fear and Stress|Acute anxiety, panic, short-term management of noise phobias]]  || Hepatic necrosis after oral dosing in cats (potentially fatal), Sedation, ataxia, increased appetite, paradoxical excitation, amnesia
 
|-
 
|-
 
| '''Tricyclic Antidepressants (TCAs)''' || Amitriptyline, [[Clomipramine]] || Anxiety, separation anxiety, canine and [[Feline Aggression|feline fear aggression]], [[Indoor Marking - Cat|feline urine marking]], [[Feline Grooming Disorders|feline compulsive grooming]], stereotypy, some narcoleptic disorders || Sedation, gastrointestinal (GI) effects, dry mouth, increased thirst, urinary retention
 
| '''Tricyclic Antidepressants (TCAs)''' || Amitriptyline, [[Clomipramine]] || Anxiety, separation anxiety, canine and [[Feline Aggression|feline fear aggression]], [[Indoor Marking - Cat|feline urine marking]], [[Feline Grooming Disorders|feline compulsive grooming]], stereotypy, some narcoleptic disorders || Sedation, gastrointestinal (GI) effects, dry mouth, increased thirst, urinary retention
Line 24: Line 25:
 
| '''Selective Serotonin Reuptake Inhibitors (SSRIs)''' || [[Fluoxetine]], Fluvoxamine, Paroxetine, Sertraline || [[Feline Aggression|Aggression]], canine separation anxiety, [[Feline Compulsive Disorders|compulsive disorders]], [[Indoor Marking - Cat|feline urine marking]] || Lethargy, inappetence, anorexia, GI effects
 
| '''Selective Serotonin Reuptake Inhibitors (SSRIs)''' || [[Fluoxetine]], Fluvoxamine, Paroxetine, Sertraline || [[Feline Aggression|Aggression]], canine separation anxiety, [[Feline Compulsive Disorders|compulsive disorders]], [[Indoor Marking - Cat|feline urine marking]] || Lethargy, inappetence, anorexia, GI effects
 
|-
 
|-
| '''Beta Blockers''' || Propranolol || Canine fear aggression, noise phobia || Bradycardia, lethargy, hypotension, syncope
+
| '''Beta Blockers''' || Propranolol || Situational anxiety, social anxiety, augmentation therapy for SRI/SSRIS drugs || Bradycardia, lethargy, hypotension, syncope
 
|-
 
|-
| '''Azapirones''' || Busiprone || Phobia, anxiety, feline urine marking, interact aggression || Uncommon, not sedating
+
| '''Azapirones''' || Busiprone || Anxiety, feline urine marking, interact aggression || Uncommon, not sedating
 
|-
 
|-
| '''Triazolopyridines''' || Trazodone || ||
+
| '''Triazolopyridines''' || Trazodone || Anxiety, phobia, separations anxiety, used primarily as an augmentation for other psychoactive drug therapies||
 
|-
 
|-
| '''Anticonvulsants''' || Carbamazepine, Gabapentin, Levetiracetam, Phenobarbital, Potassium bromide || Canine and feline compulsive tail chasing, unprovoked canine rage aggression || Lethargy, ataxia, polyuria, polydipsia, polyphagia
+
| '''Anticonvulsants''' || Carbamazepine, Gabapentin, Levetiracetam, Phenobarbital, Potassium bromide || Behavioural problems arising from focal seizures (e.g. aggression, tail chasing) || Lethargy, ataxia, polyuria, polydipsia, polyphagia
 
|-
 
|-
| '''Hormones''' || Medroxyprogesterone acetate, Megestrol acetate || Last resort for aggression and feline urine marking || Polyphagia, polydipsia, sedation, diabete mellitus, pyometra, mammary hyperplasia, endometrial hyperplasia, carcinoma
+
| '''Glial Modulators''' || Propentofylline || Reduced activity in dogs (as an adjunct therapy for dogs with cognitive dysfunction syndrome) ||
|-
 
| '''Glial Modulators''' || Propentofylline || ||
 
 
|-
 
|-
 
| '''Monoamine Oxidase Inhibitors (MAO-Is)''' || [[Selegiline]] || Canine and feline cognitive dysfunction syndrome, fear related problems, spraying, hyperactivity, compulsive/stereoptypical disorders, specific phobias || GI effects, restlessness or lethargy, anorexia
 
| '''Monoamine Oxidase Inhibitors (MAO-Is)''' || [[Selegiline]] || Canine and feline cognitive dysfunction syndrome, fear related problems, spraying, hyperactivity, compulsive/stereoptypical disorders, specific phobias || GI effects, restlessness or lethargy, anorexia

Revision as of 12:10, 9 September 2014


Although many drugs are used to treat behavioural conditions in animals, there are only three psychoactive drugs specifically licensed for use in companion animals to treat behavioural problems. These are:

  • Clomipramine (EU and USA license for the treatment of separation related problems in dogs).
  • Selegiline (EU License for the treatment of behavioural problems with an emotional underlying origin).
  • Fluoxetine (EU and USA license for the treatment of separation anxiety in dogs, when used in combination with behavioural therapy. Subsequently withdrawn from European market).

No psychoactive drugs are licensed for use in cats. A range of other drugs are used to treat behavioural conditions, including beta-adrenoceptor antagonists, benzodiazepines, azapirones, anticonvulsants and triazolopyridines. Some of these drugs are licensed for use in a companion animal species for another condition, but many are not licensed for use in any companion animal species. Examples are listed in the table below, however, most uses listed are unapproved, care should therefore be taken with their use:


Class of Drug Drugs Uses Side Effects
Tranquillisers Acepromazine Sedation/restraint (no specific indication in behavioural therapy) Hypotension, CNS stimulation, contradictory responses. Caution in boxers and greyhounds
Benzodiazepines Alprazolam, Clonazepam, Clorazepate, Diazepam, Lorazepam, Oxazepam Acute anxiety, panic, short-term management of noise phobias Hepatic necrosis after oral dosing in cats (potentially fatal), Sedation, ataxia, increased appetite, paradoxical excitation, amnesia
Tricyclic Antidepressants (TCAs) Amitriptyline, Clomipramine Anxiety, separation anxiety, canine and feline fear aggression, feline urine marking, feline compulsive grooming, stereotypy, some narcoleptic disorders Sedation, gastrointestinal (GI) effects, dry mouth, increased thirst, urinary retention
Selective Serotonin Reuptake Inhibitors (SSRIs) Fluoxetine, Fluvoxamine, Paroxetine, Sertraline Aggression, canine separation anxiety, compulsive disorders, feline urine marking Lethargy, inappetence, anorexia, GI effects
Beta Blockers Propranolol Situational anxiety, social anxiety, augmentation therapy for SRI/SSRIS drugs Bradycardia, lethargy, hypotension, syncope
Azapirones Busiprone Anxiety, feline urine marking, interact aggression Uncommon, not sedating
Triazolopyridines Trazodone Anxiety, phobia, separations anxiety, used primarily as an augmentation for other psychoactive drug therapies
Anticonvulsants Carbamazepine, Gabapentin, Levetiracetam, Phenobarbital, Potassium bromide Behavioural problems arising from focal seizures (e.g. aggression, tail chasing) Lethargy, ataxia, polyuria, polydipsia, polyphagia
Glial Modulators Propentofylline Reduced activity in dogs (as an adjunct therapy for dogs with cognitive dysfunction syndrome)
Monoamine Oxidase Inhibitors (MAO-Is) Selegiline Canine and feline cognitive dysfunction syndrome, fear related problems, spraying, hyperactivity, compulsive/stereoptypical disorders, specific phobias GI effects, restlessness or lethargy, anorexia


Benzodiazepines are the only class of drug that consistently succeeds in all models, but this may be why they have a dangerous disinhibitory effect on aggression. These drugs eliminate avoidant responses to many kinds of aversive events, increasing confidence in a number of exploratory tests. This is why benzodiazepines can cause dangerous levels of disinhibition in aggressive dogs. Benzodiazepines also inhibit memory formation by affecting NMDA (glutamate) receptors in the hippocampus, which limits their usefulness in behavioural therapy where any kind of learning is required, which is in most situations. They are useful for memory blocking if given at sub-sedative doses prior to or during a predicted traumatic event such as a thunderstorm. When used at low doses, they act as mild tranquillisers, this can help moderate excitement. At medium doses they lessen anxiety, which can encourage social interaction in a constructive way [1].

Drugs such as Acepromazine (ACP), which act on dopamine receptors, and synthetic hormone analogues like megestrol acetate (Ovarid), have little or no rational use in behavioural therapy for reasons of non-specificity, and adverse effects which make their use unjustifiable.

Phenothiazines such as ACP have a very varied level of effect and duration of action and dull both normal and abnormal behaviours which is an out of date approach to behavioural therapy[1].

The first port of call when using medication for behavioural problems should be drugs licensed for veterinary use. These drugs have established data about their efficacy, side effects, contraindications and toxicity, which makes expected outcomes more reliable[2].

References

  1. 1.0 1.1 Overall, K.L., 2004. Paradigms for pharmacologic use as a treatment component in feline behavioral medicine. Journal of Feline Medicine and Surgery 6, 29-42.
  2. Merck Veterinary Manual (10th Edition) - Behaviour. 2011 The Merck Publishing Group.